PharmaCielo Ltd.

PharmaCielo Ltd.

PCLOF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$7.27M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
PharmaCielo Ltd.PharmaCielo Ltd.-2.4-35%--1.7

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$7.27 Million
Enterprise Value$25.41 Million
Earnings per Share$-0.01
Beta1.06
Outstanding Shares206,996,707

Return

Return on Equity34.71%ROE
Return on Assets-29.13%
Return on Invested Capital8.95%

Valuation & Multiples

P/E Ratio-2.41P/E Ratio
PEG-22.83PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.04Price to Book Ratio
Enterprise Value to Revenue7.05
Enterprise Value to EBIT-26.53
Enterprise Value to Net Income-7
Total Debt to Enterprise0.72
Debt to Equity-1.7Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
July 30, 2026
EPS
-$0.00
Est. -$0.02
Revenue
$978,621
Est. $5.17 M

Next Earnings Call

Expected Date
November 26, 2026
EPS Estimate
-$0.02
Consensus analyst estimate
Revenue Estimate
$3.62 M
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About PharmaCielo Ltd.

268 employees
CEO: Marc Lustig

PharmaCielo Ltd., operating alongside its subsidiary, specializes in the cultivation, processing, production, and distribution of medical-grade cannabis extracts, including tetrahydrocannabinol (THC), and associated products. In addition...